Zhenmei An
-
- Pituitary Gland Disorders and Treatments 10
- Diet, Metabolism, and Disease 7
- Diabetes, Cardiovascular Risks, and Lipoproteins 5
- Growth Hormone and Insulin-like Growth Factors 4
- Diabetes Management and Research 3
-
- Liver Disease Diagnosis and Treatment 14
-
- Adrenal and Paraganglionic Tumors 6
-
- Endoplasmic Reticulum Stress and Disease 4
- Co-authors
- He HeYuping ZengShuangqing LiMei ZhangKang AnSheyu LiKai YuHuiwen Tan
- Partner nations
- ChinaFranceUnited Kingdom
In The Last Decade
Zhenmei An
43 papers receiving 481 citations
Peers
Comparison fields: 5 of 84
- Endocrinology, Diabetes and Metabolism 251
- Epidemiology 167
- Hepatology 32
- Pathology and Forensic Medicine 49
- Physiology 66
Countries citing papers authored by Zhenmei An
This map shows the geographic impact of Zhenmei An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenmei An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenmei An more than expected).
Fields of papers citing papers by Zhenmei An
This network shows the impact of papers produced by Zhenmei An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenmei An. The network helps show where Zhenmei An may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhenmei An, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 21 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 32 | |
| 7 | 2023 | 18 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 29 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 23 | |
| 13 | 2020 | 8 | |
| 14 | 2020 | 10 | |
| 15 | 2020 | 15 | |
| 16 | 2019 | 10 | |
| 17 | 2018 | 13 | |
| 18 | 2017 | 29 | |
| 19 | 2016 | 2 | |
| 20 | [The diagnostic value of serum beta-hydroxybutyrate in diabetic ketosis or diabetic ketoacidosis]. | 2014 | 2 |
About Zhenmei An
Zhenmei An is a scholar working on Endocrinology, Diabetes and Metabolism, Geriatrics and Gerontology and Epidemiology, having authored 47 papers that have together received 490 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (14 papers), Pituitary Gland Disorders and Treatments (10 papers), Diet, Metabolism, and Disease (7 papers), Adrenal and Paraganglionic Tumors (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers) and Diabetes Management and Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (251 citations), Epidemiology (167 citations) and Hepatology (32 citations). Zhenmei An has collaborated with scholars based in China, France and United Kingdom. Frequent co-authors include He He, Yuping Zeng, Shuangqing Li, Mei Zhang, Kang An, Sheyu Li, Kai Yu, Huiwen Tan, Nanwei Tong and Lin Zhang. Their work appears in journals such as PLoS ONE, Scientific Reports and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.